Literature DB >> 19231103

Does three-dimensional external beam partial breast irradiation spare lung tissue compared with standard whole breast irradiation?

Anudh K Jain1, Laura A Vallow, Ashley A Gale, Steven J Buskirk.   

Abstract

PURPOSE: To determine whether three-dimensional conformal partial breast irradiation (3D-PBI) spares lung tissue compared with whole breast irradiation (WBI) and to include the biologically equivalent dose (BED) to account for differences in fractionation. METHODS AND MATERIALS: Radiotherapy treatment plans were devised for WBI and 3D-PBI for 25 consecutive patients randomized on the NSABP B-39/RTOG 0413 protocol at Mayo Clinic in Jacksonville, Florida. WBI plans were for 50 Gy in 25 fractions, and 3D-PBI plans were for 38.5 Gy in 10 fractions. Volume of ipsilateral lung receiving 2.5, 5, 10, and 20 Gy was recorded for each plan. The linear quadratic equation was used to calculate the corresponding dose delivered in 10 fractions and volume of ipsilateral lung receiving these doses was recorded for PBI plans. Ipsilateral mean lung dose was recorded for each plan and converted to BED.
RESULTS: There was a significant decrease in volume of lung receiving 20 Gy with PBI (median, 4.4% vs. 7.5%; p < 0.001), which remained after correction for fractionation (median, 5.6% vs. 7.5%; p = 0.02). Mean lung dose was lower for PBI (median, 3.46 Gy vs. 4.57 Gy; p = 0.005), although this difference lost significance after conversion to BED (median, 3.86 Gy(3) vs 4.85 Gy(3), p = 0.07). PBI plans exposed more lung to 2.5 and 5 Gy.
CONCLUSIONS: 3D-PBI exposes greater volumes of lung tissue to low doses of radiation and spares the amount of lung receiving higher doses when compared with WBI.

Entities:  

Mesh:

Year:  2009        PMID: 19231103     DOI: 10.1016/j.ijrobp.2008.10.041

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Partial breast irradiation versus whole breast radiotherapy for early breast cancer.

Authors:  Brigid E Hickey; Margot Lehman
Journal:  Cochrane Database Syst Rev       Date:  2021-08-30

2.  Dosimetric comparison of normal structures associated with accelerated partial breast irradiation and whole breast irradiation delivered by intensity modulated radiotherapy for early breast cancer after breast conserving surgery.

Authors:  S Wu; Z He; J Guo; F Li; Q Lin; X Guan
Journal:  Clin Transl Oncol       Date:  2013-04-25       Impact factor: 3.405

Review 3.  Partial breast irradiation for early breast cancer.

Authors:  Brigid E Hickey; Margot Lehman; Daniel P Francis; Adrienne M See
Journal:  Cochrane Database Syst Rev       Date:  2016-07-18

4.  The role of preoperative bilateral breast magnetic resonance imaging in patient selection for partial breast irradiation in ductal carcinoma in situ.

Authors:  Kristin V Kowalchik; Laura A Vallow; Michelle McDonough; Colleen S Thomas; Michael G Heckman; Jennifer L Peterson; Cameron D Adkisson; Christopher Serago; Steven J Buskirk; Sarah A McLaughlin
Journal:  Int J Surg Oncol       Date:  2012-05-13

5.  Plan quality assessment of modern radiotherapy delivery techniques in left-sided breast cancer: an analysis stratified by target delineation guidelines.

Authors:  Irfan Ahmad; Kundan Singh Chufal; Chandi Prasad Bhatt; Alexis Andrew Miller; Ram Bajpai; Akanksha Chhabra; Rahul Lal Chowdhary; Anjali Kakria Pahuja; Munish Gairola
Journal:  BJR Open       Date:  2020-12-11

6.  Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers.

Authors:  Jean-Philippe Pignol; Nienke Hoekstra; Derek Wilke; Hannah Dahn; Maureen Nolan; Frank Vicini
Journal:  Front Oncol       Date:  2021-08-09       Impact factor: 6.244

7.  Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database.

Authors:  Nikola Cihoric; Alexandros Tsikkinis; Cristina Gutierrez Miguelez; Vratislav Strnad; Ivan Soldatovic; Pirus Ghadjar; Branislav Jeremic; Alan Dal Pra; Daniel M Aebersold; Kristina Lössl
Journal:  Radiat Oncol       Date:  2016-03-22       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.